0002066836 2025-11-01 2026-04-30 0002066836 2026-06-10 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2025-01-31 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2024-12-01 2025-01-31 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2025-05-31 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2025-05-01 2025-05-31 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2024-11-01 2025-10-31 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2025-10-23 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2025-10-28 2025-10-28 0002066836 cnxu:EntityRelatedToBoardOfDirectorsMember cnxu:NonBrokeredPrivatePlacementsMember 2025-10-28 2025-10-28 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2025-11-12 2025-11-12 0002066836 cnxu:EntityRelatedToBoardOfDirectorsMember cnxu:NonBrokeredPrivatePlacementsMember 2025-11-12 2025-11-12 0002066836 cnxu:EntityRelatedToBoardOfDirectorsMember cnxu:NonBrokeredPrivatePlacementsMember 2025-11-12 0002066836 cnxu:EntityRelatedToBoardOfDirectorsMember cnxu:NonBrokeredPrivatePlacementsMember 2026-01-26 2026-01-26 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2026-01-20 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2026-03-23 2026-03-23 0002066836 cnxu:NonBrokeredPrivatePlacementsMember 2026-03-23 0002066836 cnxu:BrokeredPrivatePlacementsMember 2025-07-31 0002066836 cnxu:BrokeredPrivatePlacementsMember 2025-09-02 2025-09-02 0002066836 cnxu:BrokeredPrivatePlacementsMember 2025-09-18 2025-09-18 0002066836 cnxu:BrokeredPrivatePlacementsMember 2025-10-07 2025-10-07 0002066836 cnxu:BrokeredPrivatePlacementsMember 2025-08-01 2025-10-07 0002066836 cnxu:BrokerMember cnxu:BrokeredPrivatePlacementsMember 2025-08-01 2025-10-07 0002066836 cnxu:ConsultantMember cnxu:ServiceAgreementMember 2025-05-08 0002066836 cnxu:ConsultantMember cnxu:ServiceAgreementMember 2025-10-31 0002066836 cnxu:ConsultantMember cnxu:ServiceAgreementMember 2025-05-08 2025-05-08 0002066836 cnxu:ConsultantMember cnxu:ServiceAgreementMember 2026-02-01 2026-04-30 0002066836 cnxu:ConsultantMember cnxu:ServiceAgreementMember 2025-11-01 2026-04-30 0002066836 cnxu:ConsultantMember cnxu:ServiceAgreementMember 2026-04-30 0002066836 us-gaap:RestrictedStockUnitsRSUMember 2025-06-27 2025-06-27 0002066836 srt:DirectorMember 2025-11-01 2026-04-30 0002066836 cnxu:ConsultantMember 2025-05-08 2025-05-08 0002066836 cnxu:ConsultantMember 2025-10-31 0002066836 cnxu:ConsultantMember 2026-02-01 2026-04-30 0002066836 cnxu:ConsultantMember 2025-11-01 2026-04-30 0002066836 cnxu:ConsultantMember 2026-04-30 0002066836 cnxu:EmployeesAndDirectorMember 2025-05-01 2025-05-31 0002066836 cnxu:DirectorInSettlementOfFeesMember 2026-03-17 2026-03-17 0002066836 cnxu:DirectorInSettlementOfFeesMember 2026-03-17 0002066836 2024-11-01 2025-04-30 0002066836 srt:DirectorMember 2025-01-21 2025-01-21 0002066836 srt:DirectorMember 2025-02-01 2025-04-30 0002066836 srt:DirectorMember 2024-11-01 2025-04-30 0002066836 cnxu:ThreeDirectorsMember cnxu:MilestoneThreeMember 2025-06-01 2025-06-05 0002066836 cnxu:ThreeDirectorsMember cnxu:MilestoneOneMember 2024-11-01 2025-10-31 0002066836 cnxu:ThreeDirectorsMember cnxu:MilestoneFourMember 2026-02-01 2026-04-30 0002066836 cnxu:ThreeDirectorsMember cnxu:MilestoneFourMember 2025-11-01 2026-04-30 0002066836 cnxu:ConsultantMember cnxu:ConsultingAgreementFor24MonthMember 2025-05-01 2025-05-31 0002066836 cnxu:ConsultantMember cnxu:ConsultingAgreementFor24MonthMember 2025-10-31 0002066836 cnxu:ConsultantMember cnxu:ConsultingAgreementFor24MonthMember 2026-02-01 2026-04-30 0002066836 cnxu:ConsultantMember cnxu:ConsultingAgreementFor24MonthMember 2025-11-01 2026-04-30 0002066836 cnxu:ConsultantMember cnxu:ConsultingAgreementFor24MonthMember 2026-04-30 0002066836 srt:DirectorMember 2025-12-23 2025-12-23 0002066836 cnxu:WarrantExerciseIncentiveProgramMember 2025-10-01 2025-10-01 0002066836 cnxu:WarrantExerciseIncentiveProgramMember 2025-10-01 0002066836 cnxu:WarrantExerciseIncentiveProgramMember 2026-02-11 2026-02-11 0002066836 cnxu:StockIncentivePlanMember 2025-06-07 0002066836 cnxu:EmployeeMember 2025-11-01 2025-11-30 0002066836 cnxu:EmployeeMember 2026-02-01 2026-04-30 0002066836 cnxu:EmployeeMember 2025-11-01 2026-04-30 0002066836 cnxu:ConsultantAndThreeAdvisorsMember 2026-02-09 2026-02-09 0002066836 cnxu:EachIndividualMember 2026-02-09 2026-02-09 0002066836 cnxu:ConsultantAndThreeAdvisorsMember 2026-02-01 2026-04-30 0002066836 cnxu:ConsultantAndThreeAdvisorsMember 2025-11-01 2026-04-30 0002066836 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2026-04-30 0002066836 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2025-10-31 0002066836 srt:MinimumMember us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2025-10-31 0002066836 srt:MaximumMember us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2025-10-31 0002066836 us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2025-11-01 2026-04-30 0002066836 srt:MinimumMember us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2024-11-01 2025-10-31 0002066836 srt:MaximumMember us-gaap:WarrantMember us-gaap:PrivatePlacementMember 2024-11-01 2025-10-31 0002066836 srt:MinimumMember us-gaap:WarrantMember cnxu:CompensationMember 2025-10-31 0002066836 us-gaap:WarrantMember cnxu:CompensationMember 2026-04-30 0002066836 srt:MaximumMember us-gaap:WarrantMember cnxu:CompensationMember 2025-10-31 0002066836 us-gaap:WarrantMember cnxu:CompensationMember 2025-11-01 2026-04-30 0002066836 srt:MinimumMember us-gaap:WarrantMember cnxu:CompensationMember 2024-11-01 2025-10-31 0002066836 srt:MaximumMember us-gaap:WarrantMember cnxu:CompensationMember 2024-11-01 2025-10-31 0002066836 us-gaap:WarrantMember cnxu:IncentiveProgramMember 2026-04-30 0002066836 us-gaap:WarrantMember cnxu:IncentiveProgramMember 2025-11-01 2026-04-30 0002066836 us-gaap:EmployeeStockOptionMember 2026-04-30 0002066836 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2025-10-31 0002066836 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2025-10-31 0002066836 us-gaap:EmployeeStockOptionMember 2025-11-01 2026-04-30 0002066836 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2024-11-01 2025-10-31 0002066836 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2024-11-01 2025-10-31 0002066836 srt:MinimumMember us-gaap:EmployeeStockOptionMember 2025-11-01 2026-04-30 0002066836 srt:MaximumMember us-gaap:EmployeeStockOptionMember 2025-11-01 2026-04-30 0002066836 us-gaap:WarrantMember 2024-10-31 0002066836 us-gaap:WarrantMember 2023-11-01 2024-10-31 0002066836 us-gaap:WarrantMember 2024-11-01 2025-10-31 0002066836 us-gaap:WarrantMember 2025-10-31 0002066836 us-gaap:WarrantMember 2025-11-01 2026-04-30 0002066836 us-gaap:WarrantMember 2026-04-30 0002066836 us-gaap:EmployeeStockOptionMember 2024-10-31 0002066836 us-gaap:EmployeeStockOptionMember 2024-11-01 2025-10-31 0002066836 us-gaap:EmployeeStockOptionMember 2025-10-31 0002066836 us-gaap:EmployeeStockOptionMember 2023-11-01 2024-10-31 0002066836 us-gaap:PrivatePlacementMember 2025-11-01 2026-04-30 0002066836 cnxu:CompensationMember 2025-11-01 2026-04-30 0002066836 cnxu:IncentiveProgramMember 2025-11-01 2026-04-30 0002066836 2026-02-01 2026-04-30 0002066836 2025-02-01 2025-04-30 0002066836 2026-04-30 0002066836 2025-10-31 0002066836 cnxu:WarrantIncentiveProgramMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-12 0002066836 srt:DirectorMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-14 0002066836 srt:DirectorMember us-gaap:SubsequentEventMember 2026-05-14 0002066836 us-gaap:SubsequentEventMember 2026-05-27 0002066836 srt:DirectorMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-22 0002066836 cnxu:VendorMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-22 0002066836 cnxu:VendorMember us-gaap:SubsequentEventMember 2026-05-22 0002066836 cnxu:FormerDirectorMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-28 0002066836 cnxu:VendorMember us-gaap:SubsequentEventMember 2026-05-01 2026-05-28 0002066836 cnxu:VendorMember us-gaap:SubsequentEventMember 2026-05-28 0002066836 us-gaap:MajorityShareholderMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-08 0002066836 cnxu:WarrantIncentiveProgramMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-04 0002066836 cnxu:BoardMembersMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-11 0002066836 srt:BoardOfDirectorsChairmanMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-11 0002066836 cnxu:NominatingAndGovernanceCommitteeMembersMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-11 0002066836 cnxu:ChairmanOfNominatingAndGovernanceCommitteeMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-11 0002066836 cnxu:CompensationCommitteeMembersMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-11 0002066836 cnxu:ChairmanOfCompensationCommitteeMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-11 0002066836 cnxu:AuditCommitteeMembersMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-11 0002066836 cnxu:ChairmanOfAuditCommitteeMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-11 0002066836 cnxu:ChiefCommercialOfficerMember us-gaap:SubsequentEventMember 2026-06-01 2026-06-11 0002066836 us-gaap:PatentsMember 2023-11-20 2023-11-20 0002066836 us-gaap:PatentsMember 2026-04-30 0002066836 us-gaap:PatentsMember 2025-10-31 0002066836 us-gaap:PatentsMember 2025-11-01 2026-04-30 0002066836 us-gaap:PatentsMember 2024-11-01 2025-04-30 0002066836 cnxu:TargetCompanyMember 2025-05-14 0002066836 cnxu:TargetCompanyMember 2025-05-01 2025-05-14 0002066836 cnxu:TargetCompanyMember 2025-10-31 0002066836 cnxu:TargetCompanyMember 2026-03-01 2026-03-24 0002066836 2025-04-10 2025-04-10 0002066836 2025-04-21 2025-04-21 0002066836 cnxu:SeriesSeedPreferredStockMember 2026-04-30 0002066836 2024-12-01 2024-12-30 0002066836 2024-12-31 0002066836 2025-06-05 0002066836 2025-07-31 0002066836 2025-07-01 2025-07-31 0002066836 us-gaap:PrivatePlacementMember 2025-10-01 2025-10-28 0002066836 us-gaap:PrivatePlacementMember 2025-10-28 0002066836 us-gaap:PrivatePlacementMember 2026-03-01 2026-03-23 0002066836 us-gaap:PrivatePlacementMember 2026-03-23 0002066836 us-gaap:WarrantMember 2025-11-01 2026-04-30 0002066836 us-gaap:WarrantMember 2024-11-01 2025-04-30 0002066836 us-gaap:StockOptionMember 2025-11-01 2026-04-30 0002066836 us-gaap:StockOptionMember 2024-11-01 2025-04-30 0002066836 us-gaap:EquipmentMember 2026-04-30 0002066836 cnxu:LabEquipmentMember 2026-04-30 0002066836 us-gaap:FurnitureAndFixturesMember 2026-04-30 0002066836 us-gaap:ComputerEquipmentMember 2026-04-30 0002066836 cnxu:LoanAgreementWithUniversityOfBritishColumbiaMember 2023-11-20 0002066836 cnxu:LoanAgreementWithUniversityOfBritishColumbiaMember 2024-10-31 0002066836 cnxu:LoanAgreementWithUniversityOfBritishColumbiaMember 2025-03-01 2025-03-04 0002066836 cnxu:LoanAgreementWithUniversityOfBritishColumbiaMember 2026-02-01 2026-04-30 0002066836 cnxu:LoanAgreementWithUniversityOfBritishColumbiaMember 2025-02-01 2025-04-30 0002066836 cnxu:LoanAgreementWithUniversityOfBritishColumbiaMember 2025-11-01 2026-04-30 0002066836 cnxu:LoanAgreementWithUniversityOfBritishColumbiaMember 2024-11-01 2025-04-30 0002066836 us-gaap:FurnitureAndFixturesMember 2025-10-31 0002066836 us-gaap:EquipmentMember 2025-10-31 0002066836 us-gaap:ComputerEquipmentMember 2025-10-31 0002066836 us-gaap:PreferredStockMember 2025-10-31 0002066836 us-gaap:CommonStockMember 2025-10-31 0002066836 us-gaap:AdditionalPaidInCapitalMember 2025-10-31 0002066836 us-gaap:RetainedEarningsMember 2025-10-31 0002066836 us-gaap:AdditionalPaidInCapitalMember 2025-11-01 2026-04-30 0002066836 us-gaap:CommonStockMember 2025-11-01 2026-04-30 0002066836 us-gaap:RetainedEarningsMember 2026-04-30 0002066836 us-gaap:AdditionalPaidInCapitalMember 2026-04-30 0002066836 us-gaap:CommonStockMember 2026-04-30 0002066836 us-gaap:PreferredStockMember 2026-04-30 0002066836 2026-01-31 0002066836 us-gaap:RetainedEarningsMember 2026-01-31 0002066836 us-gaap:AdditionalPaidInCapitalMember 2026-01-31 0002066836 us-gaap:CommonStockMember 2026-01-31 0002066836 us-gaap:PreferredStockMember 2026-01-31 0002066836 2024-10-31 0002066836 us-gaap:RetainedEarningsMember 2024-10-31 0002066836 us-gaap:AdditionalPaidInCapitalMember 2024-10-31 0002066836 us-gaap:CommonStockMember 2024-10-31 0002066836 us-gaap:PreferredStockMember 2024-10-31 0002066836 2025-04-30 0002066836 us-gaap:RetainedEarningsMember 2025-04-30 0002066836 us-gaap:AdditionalPaidInCapitalMember 2025-04-30 0002066836 us-gaap:CommonStockMember 2025-04-30 0002066836 us-gaap:PreferredStockMember 2025-04-30 0002066836 2025-02-01 0002066836 us-gaap:RetainedEarningsMember 2025-02-01 0002066836 us-gaap:AdditionalPaidInCapitalMember 2025-02-01 0002066836 us-gaap:CommonStockMember 2025-02-01 0002066836 us-gaap:PreferredStockMember 2025-02-01 0002066836 us-gaap:CommonStockMember 2026-02-01 2026-04-30 0002066836 us-gaap:CommonStockMember 2024-11-01 2025-04-30 0002066836 us-gaap:AdditionalPaidInCapitalMember 2024-11-01 2025-04-30 0002066836 us-gaap:AdditionalPaidInCapitalMember 2025-02-02 2025-04-30 0002066836 us-gaap:RetainedEarningsMember 2024-11-01 2025-04-30 0002066836 us-gaap:RetainedEarningsMember 2025-02-02 2025-04-30 0002066836 us-gaap:RetainedEarningsMember 2026-02-01 2026-04-30 0002066836 us-gaap:AdditionalPaidInCapitalMember 2026-02-01 2026-04-30 0002066836 2025-02-02 2025-04-30 0002066836 us-gaap:RetainedEarningsMember 2025-11-01 2026-04-30 0002066836 cnxu:FounderAndFormerCeoMember 2026-04-30 0002066836 cnxu:FounderAndFormerCeoMember 2025-10-31 0002066836 srt:DirectorMember 2023-10-01 2023-10-31 0002066836 srt:DirectorMember 2025-04-01 2025-04-30 0002066836 srt:DirectorMember 2025-04-30 0002066836 srt:DirectorMember 2025-06-01 2025-06-05 0002066836 srt:DirectorMember 2025-06-05 0002066836 srt:DirectorMember cnxu:MilestoneOneMember 2025-06-01 2025-06-05 0002066836 srt:DirectorMember cnxu:MilestoneTwoMember 2025-06-01 2025-06-05 0002066836 srt:DirectorMember cnxu:MilestoneThreeMember 2025-06-01 2025-06-05 0002066836 srt:DirectorMember cnxu:MilestoneFourMember 2025-06-01 2025-06-05 0002066836 srt:DirectorMember cnxu:MilestoneFourMember 2026-02-01 2026-04-30 0002066836 srt:DirectorMember cnxu:MilestoneFourMember 2025-11-01 2026-04-30 0002066836 srt:DirectorMember 2025-11-01 2025-11-04 0002066836 cnxu:DirectorTwoMember 2023-10-01 2023-10-31 0002066836 cnxu:DirectorTwoMember 2025-03-01 2025-03-31 0002066836 cnxu:DirectorTwoMember 2025-11-01 2025-11-30 0002066836 cnxu:DirectorTwoMember 2026-02-01 2026-04-30 0002066836 cnxu:DirectorTwoMember 2025-02-01 2025-04-30 0002066836 cnxu:DirectorTwoMember 2025-11-01 2026-04-30 0002066836 cnxu:DirectorTwoMember 2024-11-01 2025-04-30 0002066836 cnxu:DirectorTwoMember 2026-04-30 0002066836 cnxu:DirectorTwoMember 2025-04-30 0002066836 cnxu:DirectorTwoMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorTwoMember 2025-06-05 0002066836 cnxu:DirectorTwoMember cnxu:MilestoneOneMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorTwoMember cnxu:MilestoneTwoMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorTwoMember cnxu:MilestoneThreeMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorTwoMember cnxu:MilestoneFourMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorTwoMember cnxu:MilestoneFourMember 2026-02-01 2026-04-30 0002066836 cnxu:DirectorTwoMember cnxu:MilestoneFourMember 2025-11-01 2026-04-30 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2025-05-01 2025-05-31 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2026-02-01 2026-04-30 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2025-02-01 2025-04-30 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2025-11-01 2026-04-30 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2024-11-01 2025-04-30 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2026-04-30 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2025-04-30 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2025-06-05 0002066836 cnxu:DirectorThreeAndFormerCeoMember cnxu:MilestoneOneMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorThreeAndFormerCeoMember cnxu:MilestoneTwoMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorThreeAndFormerCeoMember cnxu:MilestoneThreeMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorThreeAndFormerCeoMember cnxu:MilestoneFourMember 2025-06-01 2025-06-05 0002066836 cnxu:DirectorThreeAndFormerCeoMember cnxu:MilestoneFourMember 2026-02-01 2026-04-30 0002066836 cnxu:DirectorThreeAndFormerCeoMember cnxu:MilestoneFourMember 2025-11-01 2026-04-30 0002066836 cnxu:DirectorThreeAndFormerCeoMember 2025-12-01 2025-12-31 0002066836 cnxu:CmoFormerDirectorFourAndFormerPresidentMember 2025-04-01 2025-04-30 0002066836 cnxu:CmoFormerDirectorFourAndFormerPresidentMember 2024-11-01 2025-04-30 0002066836 cnxu:CmoFormerDirectorFourAndFormerPresidentMember 2025-04-30 0002066836 cnxu:CmoFormerDirectorFourAndFormerPresidentMember 2026-02-01 2026-04-30 0002066836 cnxu:CmoFormerDirectorFourAndFormerPresidentMember 2025-11-01 2026-04-30 0002066836 cnxu:CmoFormerDirectorFourAndFormerPresidentMember 2025-10-01 2025-10-15 0002066836 cnxu:CmoFormerDirectorFourAndFormerPresidentMember 2025-10-31 0002066836 cnxu:CeoPresidentAndDirectorSixMember 2025-10-01 2025-10-15 0002066836 cnxu:DirectorFiveMember 2026-02-01 2026-04-30 0002066836 cnxu:DirectorSevenMember 2025-10-01 2025-10-23 0002066836 cnxu:DirectorEightMember 2026-02-01 2026-04-30 0002066836 srt:ChiefFinancialOfficerMember 2026-02-01 2026-04-30 0002066836 srt:ChiefFinancialOfficerMember 2025-02-01 2025-04-30 0002066836 cnxu:DirectorSevenMember 2026-02-01 2026-04-30 0002066836 cnxu:DirectorSevenMember 2025-11-01 2026-04-30 0002066836 cnxu:DirectorEightMember 2025-11-01 2026-04-30 0002066836 srt:ChiefFinancialOfficerMember 2026-04-30 0002066836 srt:ChiefFinancialOfficerMember 2025-10-31 0002066836 cnxu:DirectorSevenMember 2026-04-30 0002066836 cnxu:DirectorEightMember 2026-04-30 0002066836 cnxu:DirectorFiveMember cnxu:MedicalAdvisoryAgreementMember 2025-11-01 2025-11-30 0002066836 cnxu:DirectorFiveMember 2026-04-30 0002066836 srt:ChiefFinancialOfficerMember 2025-10-01 2025-10-15 0002066836 srt:ChiefFinancialOfficerMember 2025-10-15 0002066836 cnxu:ChiefScienceOfficerMember 2025-10-01 2025-10-15 0002066836 cnxu:ChiefScienceOfficerMember 2025-10-15 0002066836 cnxu:CeoPresidentAndDirectorSixMember 2026-02-01 2026-04-30 0002066836 cnxu:CeoPresidentAndDirectorSixMember 2025-11-01 2026-04-30 0002066836 cnxu:CeoPresidentAndDirectorSixMember 2025-10-31 0002066836 cnxu:ChiefScienceOfficerMember 2025-10-31 0002066836 cnxu:DirectorFiveMember cnxu:MedicalAdvisoryAgreementMember 2026-02-01 2026-04-30 0002066836 cnxu:DirectorFiveMember cnxu:MedicalAdvisoryAgreementMember 2025-11-01 2026-04-30 0002066836 cnxu:DirectorFiveMember 2025-11-01 2026-04-30 0002066836 cnxu:DirectorFiveMember cnxu:MedicalAdvisoryAgreementMember 2026-04-30 0002066836 cnxu:DirectorFiveMember 2026-03-01 2026-03-17 0002066836 cnxu:DirectorFiveMember 2026-03-17 0002066836 cnxu:CeoPresidentAndDirectorSixMember 2026-04-30 0002066836 srt:ChiefFinancialOfficerMember 2023-11-01 2023-11-30 0002066836 srt:ChiefFinancialOfficerMember 2025-02-01 2025-02-28 0002066836 srt:ChiefFinancialOfficerMember 2025-11-01 2026-04-30 0002066836 srt:ChiefFinancialOfficerMember 2024-11-01 2025-04-30 0002066836 cnxu:DirectorEightMember 2025-11-30 0002066836 cnxu:DirectorSevenMember 2026-03-31 0002066836 cnxu:DirectorSevenMember 2026-01-31 0002066836 cnxu:DirectorSevenMember 2025-10-28 0002066836 srt:ChiefFinancialOfficerMember 2024-11-01 2025-01-31 0002066836 cnxu:ChiefScienceOfficerMember 2025-11-01 2026-04-30 0002066836 cnxu:ChiefScienceOfficerMember 2026-02-01 2026-04-30 0002066836 cnxu:ChiefScienceOfficerMember 2025-06-01 2025-06-09 0002066836 cnxu:ChiefScienceOfficerMember 2025-05-01 2025-05-31 0002066836 cnxu:CeoPresidentAndDirectorSixMember cnxu:VestImmediatelyOnEffectiveDateMember 2025-10-01 2025-10-15 0002066836 cnxu:CeoPresidentAndDirectorSixMember cnxu:VestEachYearForFourYearsOnAnniversaryDateMember 2025-10-01 2025-10-15 0002066836 cnxu:DirectorSevenMember 2025-12-01 2025-12-31 0002066836 cnxu:DirectorSevenMember 2025-12-31 iso4217:CAD pure shares iso4217:USD iso4217:USD shares

P0Y

0002066836 false Q2 --10-31 10-Q true 2026-04-30 2026 false 001-43283 CONEXEU SCIENCES INC. NV 33-4814282 50 West Liberty Street Suite 880 Reno NV US 89501 424 333-5622 Common Stock CNXU NASDAQ No Yes Non-accelerated Filer true true false false 26758330

6848064

4808965

453974

25155

0 2000000

3037

2171

71326

609476

549930

7913685

7458413

42177

71328

12317

10712

7431

38400

11237

22754

9819

163949

176884

8199679

7688711

455055

256296

71309

76000

427967 0 543 0 44700 0 3722 3722

1003296

336018

0.001

50000000

0.001

250000000

20916173

18906066

20916

18906

15720093

11855307

-8544626

-4521520

7196383

7352693

8199679

7688711

9256

19323

20710

27215

11422

3401

17860

3964

3644 926 5676 1658

85712

56337

182757

94220

1228909 149586 1759107 196596 17618 150 25258 150

4148

8400

1085 0 2125 0

609613

83116

1335705

292802

16867

5720

23843

6349

325489

95957

592719

101347

66605

42465

129167

66133

2380368

456981

4103327

790434

-2380368

-456981

-4103327

-790434

0 0 0 43176

84295

95586

1383

4993

-8210

314

-15365

4137

76085

-1069

80221

42320

-2304283

-458050

-4023106

-748114

-2304283

-458050

-4023106

-748114

-0.11

-0.05

-0.2

-0.08

20569664

9505618

20567442

9184944

18906066

18906

11855307

-4521520

7352693

927100

927

2942424

2943351

563573

564

427364

427928

19434

44679

44698

500000 500 500

449755

564

-4023106

20916173

20916

15720093

-8544626

7196383

19846196

19846

13046899

-6240343

6826402

486970

487

1937565

1938052

563573

564

427364

427928

19434

44679

44698

263022

564

-2304283

20916173

20916

15720093

-8544626

7196383

8528024

8528

684399

-597963

94964

687500

688

549312

550000

82500

65918

66000

26686

64311

207594

208

122690

122898

-748114

9505618

9506

1513316

-1346077

176745

9505618

9506

1449005

-888027

570484

64311

-458050

9505618

9506

1513316

-1346077

176745

-4023106

-748114

12935

1133

4925

2831

-2741

0 43176

449755

64311

0 26686 44698 0

198759

164161

71309

-52738

2171

-3037

11962

-76000

59546

133737

-12317

44700 66000

-3340281

-664605

34829

18268

-34831

-18268

2000000 0

4190

427928 0

564

500

2943351

550000

98117

42177 0 543 0 427967 0

5843030

447693

2467918

-235180

4834120

314616

7302038

79436

18916

71328 0

122898

<div> 1. Nature of Operations Conexeu Sciences Inc. ("CONEXEU" or the "Company") was incorporated on November 2, 2022, pursuant to the Business Corporations Act of British Columbia, Canada. CONEXEU is a regenerative medicine company committed to developing and commercializing novel cellular therapies for skin restoration in wound care and aesthetics with the use of patent protected advanced tissue engineering and biomaterial innovations. The Company has a fiscal year-end of October 31. On April 10, 2025, the Company was continued from the jurisdiction of British Columbia, Canada to a newly incorporated Nevada corporation. The registered offices of the Company, effective April 10, 2025, is located at 50 W Liberty St., Suite 880, Reno, Nevada, 89501. Risks and Uncertainties Disruption of global financial markets and a recession or market correction, including the ongoing military conflicts between Russia and Ukraine and the related sanctions imposed against Russia as well as the conflicts between Israel and Hamas, the significant tariffs imposed by the United States on imports from other countries, the military action taken against Iran and other global macroeconomic factors such as inflation and rising interest rates, could reduce the Company's ability to access capital, which could in the future negatively affect the Company's liquidity and could materially affect the Company's business and the value of its common stock. Segment Reporting ASC Topic No. 280, Segment Reporting ("ASC 280"), establishes standards for the way that public business enterprises report information about operating segments in their financial statements and requires that those enterprises report selected information about operating segments in interim financial reports. ASC 280 also establishes standards for related disclosures about products and services, geographic areas, and major customers. The Company's business segments are based on the organization structure used by the chief operating decision maker for making operating and investment decisions and for assessing performance. Our chief executive officer, who is our chief operating decision maker, views the Company's operations and manages its business in one operating segment, which is developing and commercializing novel cellular therapies for skin restoration in wound care and aesthetics through use of patent protected advanced tissue engineering and biomaterial innovations. </div>

<div> 2. Basis of Presentation Basis of Presentation These unaudited condensed interim financial statements have been prepared in accordance with the accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by GAAP for complete financial statements. These unaudited condensed interim financial statements should be read in conjunction with the audited financial statements included in the Company's Annual Report for the fiscal year ended October 31, 2025. The accompanying unaudited condensed interim financial statements include all adjustments that are of a normal recurring nature and necessary for the fair presentation of the results for the interim periods presented. Results for interim periods are not necessarily indicative of results to be expected for the full year. The functional and presentation currency of the Company is the United States Dollars. Prior to its incorporation as a Nevada corporation, the Company's articles of incorporation had three classes of stock, Preferred Series A, Common Class A and Common Class B. The articles of incorporation allowed for unlimited shares each type to be issued and the shares had no par value. On April 10, 2025, the Company became incorporated in Nevada. The Nevada articles of incorporation authorized two types of shares, preferred stock and common stock. Each class of stock has a par value of $0.001 per share. At the date of conversion, the Company only had Common Class A shares outstanding. These converted into common stock at a ratio of 1:1. On April 21, 2025, the Board of Directors approved a 4:1 reverse stock split. These unaudited condensed interim financial statements have been adjusted retrospectively for the change of incorporation and the reverse stock split. <div> </div> Use of Estimates The preparation of these unaudited condensed interim financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of these unaudited condensed interim financial statements and reported amounts of revenues and expenses during the reporting period. Actual results could materially differ from those estimates. Going Concern These unaudited condensed interim financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. During the three months ended April 30, 2026, and 2025, the Company recorded a net loss of $2,304,283 and $458,050, respectively. During the six months ended April 30, 2026, and 2025, the Company recorded a net loss of $4,023,106 and $748,114, respectively. As of April 30, 2026, and October 31, 2025, the Company had an accumulated deficit of $8,544,626 and $4,521,520, respectively. These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date of these unaudited condensed interim financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company's ability to raise additional funds and implement its business plan. These unaudited condensed interim financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Such adjustments could be material. As of April 30, 2026, the Company had cash and cash equivalents in the amount of $6,848,064. The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company is able to obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing. </div>

0.001

1:1

4:1

-2304283

-458050

-4023106

-748114

-8544626

-4521520

6848064

<div> 3. Summary of Significant Accounting Policies The significant accounting policies applied in the preparation of these unaudited condensed interim financial statements are consistent with the accounting policies disclosed in the Company's audited financial statements for the year ended October 31, 2025. <div> Cash and Cash Equivalents Cash and cash equivalents include cash on hand, deposits held with banks, funds in transit and when applicable, short-term, highly liquid deposits which are either cashable or with original maturities of no more than three months. Cash equivalents were $5,498,339 and $0 as of April 30, 2026, and October 31, 2025. At times, the Company's cash balance exceeds the federally insured limits. The total uninsured cash and cash equivalents balance as of April 30, 2026, and October 31, 2025, were $2,874,048 and $4,554,887, respectively. </div> <div> Investment The Company has an investment of 19,327 shares of Series Seed Preferred Stock in a non-public company. This investment is less than 20% ownership in the non-public company. There is no observable market for the shares, and thus no readily determinable fair value. Due to these circumstances, the Company accounts for the investment at cost less impairment. </div> <div> </div> <div> Restricted Cash Restricted Cash equaling $453,974 represents the following: $25,464 held in a guaranteed investment certificate as collateral for the credit cards issued to the Company and $428,510 that were received from certain warrant holders who were exercising 542,648 warrants for 542,648 shares under the Company's warrant inducement program for gross proceeds of $427,967 plus subscribing to an equivalent number of new warrants (542,648 warrants) with an exercise price of $2.30 and a three year expiry date from date of issuance for gross proceeds of $543. The monies received for the warrants are held in a trust account in the Company's name, that requires the Company's lawyers to approve transfers out of the account and are restricted until the warrants are issued. The shares for these warrants exercised were issued subsequent to April 30, 2026, see Note 12 Subsequent Events. </div> <div> Fair Value of Financial Instruments Our financial assets and liabilities measured at fair value on a recurring basis consist primarily of prepaid expenses, accounts payable and accrued liabilities, due to shareholders, and loan payable. The carrying amount of prepaid expenses, accounts payable and accrued liabilities, due to shareholders approximate fair value because of the short-term maturity of such instruments. We have categorized our assets and liabilities that are valued at fair value on a recurring basis into a three-level fair value hierarchy in accordance with U.S. GAAP. Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy gives the highest priority to quoted prices in active markets for identical assets and liabilities (Level 1) and lowest priority to unobservable inputs (Level 3). Assets and liabilities recorded in the unaudited condensed balance sheets at fair value are categorized based on a hierarchy of inputs, as follows: Level 1 - Unadjusted quoted prices in active markets for identical assets or liabilities Level 2 - Quoted prices for similar assets or liabilities in active markets that are observable for the asset or liability either directly or indirectly through market corroboration, for substantially the full term of the financial instrument Level 3 - Unobservable inputs for the asset or liability The Company had no assets or liabilities required to be accounted for under the fair value hierarchy. </div> <div> Advertising Expenses Advertising expenses are expensed as incurred. Advertising expenses for the three months ended April 30, 2026, and 2025 were $9,256 and $19,323, respectively. For the six months ended April 30, 2026, and 2025, advertising expenses totaled $20,710 and $27,215, respectively </div> <div> Research and Development Expenses Research and development expenses are expensed as incurred and consist principally of internal and external costs, which include the cost of contract research services, laboratory supplies and development and manufacture of preclinical compounds and consumables for preclinical testing. Research and development expenses for the three months ended April 30, 2026, and 2025 were $66,605 and $42,465, respectively. For the six months ended April 30, 2026, and 2025, research and development expenses totaled $129,167 and $66,133, respectively </div> <div> Stock-Based Compensation The Company applies the provisions of ASC 718, Compensation-Stock Compensation ("ASC 718"), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees, including employee stock options and warrants, in the unaudited condensed interim statements of operations. <div> </div> For stock options and warrants issued to employees and members of the Company's Board of Directors (the "Board") for their services, the Company estimates each option's grant-date fair value using the Black-Scholes option pricing model. The use of the Black-Scholes option pricing model requires management to make assumptions with respect to the expected term of the option and warrant, the expected volatility of the Common Stock consistent with the expected life of the option and warrant, risk-free interest rates, and expected dividend yields of the Common Stock. For awards subject to service-based vesting conditions, including those with a graded vesting schedule, the Company recognizes stock-based compensation expense equal to the grant date fair value of stock options and warrants on a straight-line basis over the requisite service period, generally the vesting term. Forfeitures are recorded as incurred instead of estimated at the time of grant and revised. Under Accounting Standards Update ("ASU") 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Non-Employee Share-Based Payment Accounting, the Company accounts for stock options and warrants issued to non-employees for their services in accordance with ASC 718. The Company uses valuation methods and assumptions to value the stock options and warrants that are in line with the process for valuing employee stock options and warrants noted above. The fair value of the Company's stock was determined by management and, in doing so, considered in part upon third-party 409A valuations through July 31, 2025. A 409A valuation is an independent appraisal of a private company's common stock fair market value. The valuations were performed on the following dates: inception through December 30, 2024, December 31, 2024, June 5, 2025, and July 31, 2025. The Company determined the fair value of the Company's stock from inception through December 30, 2024, by using the asset approach, as this was believed to be the most appropriate method due to very limited equity issuances, limited operations, and there being significant doubt about the Company's ability to continue as a going concern. The fair value of the shares from this valuation was determined to be $0.05. The fair value of the Company's stock as of December 31, 2024, June 5, 2025, and July 31, 2025, was determined by using the market approach which was believed to be the most appropriate valuation methodology, whereby the fair value was equal to the price of the shares purchased in the most recent equity raises. The Company determined these dates for the valuations due to achievement of significant business milestones, including but not limited to, the continuation and restructuring of the Company from British Columbia, Canada to Nevada, USA, assignment of the IP patent, successes in the research and development programs and an increasing scope of potential markets for the Company's IP. The December 31, 2024, June 5, 2025, and July 31, 2025, valuations concluded that the fair value was equal to the most recent sale of equity securities, which was $0.80 (price post 4:1 reverse split), $0.40, and $2.00 respectively. Subsequent to July 31, 2025, management determined the fair value of the shares was equal to the last raised price, as on July 31, 2025, the date the Company started its Regulation Crowdfunding offering at $2.00. Based on management's use of the market approach valuation, on October 28, 2025, the Company completed a private placement issuing 891,306 shares at a price of $2.30 per share. Therefore, effective this date forward, until there is a raise supported at a different price, management determined that the fair market value of a Company's share was $2.30. On March 23, 2026, the Company completed a private placement issuing 486,970 at a price of $4.00 per share. Therefore, effective this date forward, until there is a raise supported at a different price, management determined that the fair market value of a Company's share was now $4.00. </div> <div> Net Loss Per Share The Company computes net loss per share in accordance with ASC 260, Earnings per Share ("EPS"). The Company computes basic loss per share by dividing the loss attributable to holders of Common Stock for the period by the weighted average number of shares of Common Stock outstanding during the period. The Company's warrants could potentially be exercised or converted into Common Stock and then share in the earnings of the Company. However, these convertible instruments were excluded when calculating diluted loss per share because such inclusion would be anti-dilutive for the periods presented. As a result, diluted loss per share is the same as basic loss per share for the periods presented. <div> </div> Potentially dilutive securities, which are not included in diluted weighted average shares outstanding for the six months ended April 30, 2026, and 2025, consist of the following (in common stock equivalents): <div> <table cellpadding="0" cellspacing="0" style="width: 90%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2026 </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2025 </td> </tr> <tr> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> Warrants </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> 8,733,226 </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> 1,879,054 </td> </tr> <tr> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> Options </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> 735,000 </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> 250,000 </td> </tr> </table> </div> Basic EPS as calculated in these accompanying unaudited condensed interim financial statements have included the potential dilutive effect of the weighted average of vested penny warrants outstanding. Therefore, 500,000 penny warrants have been excluded in the total anti-dilutive warrants in the table above as of April 30, 2026. There were no penny warrants outstanding as of April 30, 2025. </div> <div style="margin-top: 0pt; margin-bottom: 0pt;"> Fixed Assets Fixed assets are stated at cost less accumulated depreciation. Maintenance and repair charges are expensed as incurred. Fixed assets are depreciated under the straight-line method using the following estimated useful lives: <ul style="padding-left: 0pt; list-style-type: disc; margin-top: 0pt; margin-bottom: 0pt;"> <li style="margin-left: 65.84pt; text-align: justify; padding-left: 8.86pt; margin-top: 0pt; margin-bottom: 0pt;">Equipment - 5 years</li> <li style="margin-left: 65.84pt; text-align: justify; padding-left: 8.86pt; margin-top: 0pt; margin-bottom: 0pt;">Lab Equipment - 5 years</li> <li style="margin-left: 65.84pt; text-align: justify; padding-left: 8.86pt; margin-top: 0pt; margin-bottom: 0pt;">Furniture and fixtures - 5 years</li> <li style="margin-left: 65.84pt; text-align: justify; padding-left: 8.86pt; margin-top: 0pt; margin-bottom: 0pt;">Computer equipment - 2 years.</li> </ul> </div> <div> Leases The Company accounts for leases in accordance with Accounting Standards Codification ("ASC") Topic 842, Leases. The Company determines if an arrangement is a lease at inception. Right-of-use ("ROU") assets and lease liabilities are recognized at the lease commencement date based on the present value of lease payments over the lease term. Lease liabilities are measured using the present value of future lease payments, discounted using the interest rate implicit in the lease, if readily determinable, or the Company's incremental borrowing rate. ROU assets are measured based on the corresponding lease liability, adjusted for lease incentives, initial direct costs, and prepaid lease payments. The Company's lease terms may include options to extend or terminate the lease when it is reasonably certain that such options will be exercised. Lease expense for operating leases is recognized on a straight-line basis over the lease term. The Company does not recognize ROU assets or lease liabilities for leases until the lease commencement date. Payments made prior to lease commencement are recorded as prepaid rent or other assets, depending on their nature. </div> <div> Subsequent Events The Company evaluated subsequent events through June 11, 2026, the date in which these unaudited condensed interim financial statements were issued. </div> </div>

<div> Cash and Cash Equivalents Cash and cash equivalents include cash on hand, deposits held with banks, funds in transit and when applicable, short-term, highly liquid deposits which are either cashable or with original maturities of no more than three months. Cash equivalents were $5,498,339 and $0 as of April 30, 2026, and October 31, 2025. At times, the Company's cash balance exceeds the federally insured limits. The total uninsured cash and cash equivalents balance as of April 30, 2026, and October 31, 2025, were $2,874,048 and $4,554,887, respectively. </div>

5498339

2874048

4554887

19327

0.20

<div> Restricted Cash Restricted Cash equaling $453,974 represents the following: $25,464 held in a guaranteed investment certificate as collateral for the credit cards issued to the Company and $428,510 that were received from certain warrant holders who were exercising 542,648 warrants for 542,648 shares under the Company's warrant inducement program for gross proceeds of $427,967 plus subscribing to an equivalent number of new warrants (542,648 warrants) with an exercise price of $2.30 and a three year expiry date from date of issuance for gross proceeds of $543. The monies received for the warrants are held in a trust account in the Company's name, that requires the Company's lawyers to approve transfers out of the account and are restricted until the warrants are issued. The shares for these warrants exercised were issued subsequent to April 30, 2026, see Note 12 Subsequent Events. </div>

453974

25464

428510 542648 542648 427967 542648

2.3

543

<div> Advertising Expenses Advertising expenses are expensed as incurred. Advertising expenses for the three months ended April 30, 2026, and 2025 were $9,256 and $19,323, respectively. For the six months ended April 30, 2026, and 2025, advertising expenses totaled $20,710 and $27,215, respectively </div>

9256

19323

20710

27215

66605

42465

129167

66133

<div> Stock-Based Compensation The Company applies the provisions of ASC 718, Compensation-Stock Compensation ("ASC 718"), which requires the measurement and recognition of compensation expense for all stock-based awards made to employees, including employee stock options and warrants, in the unaudited condensed interim statements of operations. <div> </div> For stock options and warrants issued to employees and members of the Company's Board of Directors (the "Board") for their services, the Company estimates each option's grant-date fair value using the Black-Scholes option pricing model. The use of the Black-Scholes option pricing model requires management to make assumptions with respect to the expected term of the option and warrant, the expected volatility of the Common Stock consistent with the expected life of the option and warrant, risk-free interest rates, and expected dividend yields of the Common Stock. For awards subject to service-based vesting conditions, including those with a graded vesting schedule, the Company recognizes stock-based compensation expense equal to the grant date fair value of stock options and warrants on a straight-line basis over the requisite service period, generally the vesting term. Forfeitures are recorded as incurred instead of estimated at the time of grant and revised. Under Accounting Standards Update ("ASU") 2018-07, Compensation-Stock Compensation (Topic 718): Improvements to Non-Employee Share-Based Payment Accounting, the Company accounts for stock options and warrants issued to non-employees for their services in accordance with ASC 718. The Company uses valuation methods and assumptions to value the stock options and warrants that are in line with the process for valuing employee stock options and warrants noted above. The fair value of the Company's stock was determined by management and, in doing so, considered in part upon third-party 409A valuations through July 31, 2025. A 409A valuation is an independent appraisal of a private company's common stock fair market value. The valuations were performed on the following dates: inception through December 30, 2024, December 31, 2024, June 5, 2025, and July 31, 2025. The Company determined the fair value of the Company's stock from inception through December 30, 2024, by using the asset approach, as this was believed to be the most appropriate method due to very limited equity issuances, limited operations, and there being significant doubt about the Company's ability to continue as a going concern. The fair value of the shares from this valuation was determined to be $0.05. The fair value of the Company's stock as of December 31, 2024, June 5, 2025, and July 31, 2025, was determined by using the market approach which was believed to be the most appropriate valuation methodology, whereby the fair value was equal to the price of the shares purchased in the most recent equity raises. The Company determined these dates for the valuations due to achievement of significant business milestones, including but not limited to, the continuation and restructuring of the Company from British Columbia, Canada to Nevada, USA, assignment of the IP patent, successes in the research and development programs and an increasing scope of potential markets for the Company's IP. The December 31, 2024, June 5, 2025, and July 31, 2025, valuations concluded that the fair value was equal to the most recent sale of equity securities, which was $0.80 (price post 4:1 reverse split), $0.40, and $2.00 respectively. Subsequent to July 31, 2025, management determined the fair value of the shares was equal to the last raised price, as on July 31, 2025, the date the Company started its Regulation Crowdfunding offering at $2.00. Based on management's use of the market approach valuation, on October 28, 2025, the Company completed a private placement issuing 891,306 shares at a price of $2.30 per share. Therefore, effective this date forward, until there is a raise supported at a different price, management determined that the fair market value of a Company's share was $2.30. On March 23, 2026, the Company completed a private placement issuing 486,970 at a price of $4.00 per share. Therefore, effective this date forward, until there is a raise supported at a different price, management determined that the fair market value of a Company's share was now $4.00. </div>

0.05 0.8

4:1

0.4 2 2

891306

2.3

486970

<div> Net Loss Per Share The Company computes net loss per share in accordance with ASC 260, Earnings per Share ("EPS"). The Company computes basic loss per share by dividing the loss attributable to holders of Common Stock for the period by the weighted average number of shares of Common Stock outstanding during the period. The Company's warrants could potentially be exercised or converted into Common Stock and then share in the earnings of the Company. However, these convertible instruments were excluded when calculating diluted loss per share because such inclusion would be anti-dilutive for the periods presented. As a result, diluted loss per share is the same as basic loss per share for the periods presented. <div> </div> Potentially dilutive securities, which are not included in diluted weighted average shares outstanding for the six months ended April 30, 2026, and 2025, consist of the following (in common stock equivalents): <div> <table cellpadding="0" cellspacing="0" style="width: 90%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2026 </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2025 </td> </tr> <tr> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> Warrants </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> 8,733,226 </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> 1,879,054 </td> </tr> <tr> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> Options </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> 735,000 </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> 250,000 </td> </tr> </table> </div> Basic EPS as calculated in these accompanying unaudited condensed interim financial statements have included the potential dilutive effect of the weighted average of vested penny warrants outstanding. Therefore, 500,000 penny warrants have been excluded in the total anti-dilutive warrants in the table above as of April 30, 2026. There were no penny warrants outstanding as of April 30, 2025. </div>

<div> <table cellpadding="0" cellspacing="0" style="width: 90%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2026 </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2025 </td> </tr> <tr> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> Warrants </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> 8,733,226 </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> 1,879,054 </td> </tr> <tr> <td style="width: 49%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> Options </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> 735,000 </td> <td style="width: 1%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> </td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> 250,000 </td> </tr> </table> </div>

8733226

1879054

735000

250000

500000

<div style="margin-top: 0pt; margin-bottom: 0pt;"> Fixed Assets Fixed assets are stated at cost less accumulated depreciation. Maintenance and repair charges are expensed as incurred. Fixed assets are depreciated under the straight-line method using the following estimated useful lives: <ul style="padding-left: 0pt; list-style-type: disc; margin-top: 0pt; margin-bottom: 0pt;"> <li style="margin-left: 65.84pt; text-align: justify; padding-left: 8.86pt; margin-top: 0pt; margin-bottom: 0pt;">Equipment - 5 years</li> <li style="margin-left: 65.84pt; text-align: justify; padding-left: 8.86pt; margin-top: 0pt; margin-bottom: 0pt;">Lab Equipment - 5 years</li> <li style="margin-left: 65.84pt; text-align: justify; padding-left: 8.86pt; margin-top: 0pt; margin-bottom: 0pt;">Furniture and fixtures - 5 years</li> <li style="margin-left: 65.84pt; text-align: justify; padding-left: 8.86pt; margin-top: 0pt; margin-bottom: 0pt;">Computer equipment - 2 years.</li> </ul> </div>

P5Y

P2Y

<div> Subsequent Events The Company evaluated subsequent events through June 11, 2026, the date in which these unaudited condensed interim financial statements were issued. </div>

<div> 4. Fixed Assets Fixed Assets consist of the following: <div> <table cellpadding="0" cellspacing="0" style="width: 90%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td colspan="1" style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;">April 30, 2026</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;">October 31, 2025</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5.4pt;">Furniture and fixtures</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;">661</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;">400</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Lab equipment</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right;">30,085</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right;">-</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; background-color: #e6efff; padding-left: 5.4pt;">Computer equipment</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right; background-color: #e6efff;">18,366</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right; background-color: #e6efff;">18,268</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;"> </td> <td colspan="1" style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; text-align: right;">49,112</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; text-align: right;">18,668</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; background-color: #e6efff; padding-left: 5.4pt;">Less: accumulated depreciation</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right; background-color: #e6efff;">10,712</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right; background-color: #e6efff;">7,431</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; padding-left: 5.4pt;">Fixed Assets, net</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right;">38,400</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right;">11,237</td> </tr> </table> </div> Depreciation expense was $4,925 and $2,831 for the six months ended April 30, 2026, and 2025, respectively. </div>

<div> <table cellpadding="0" cellspacing="0" style="width: 90%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td colspan="1" style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;">April 30, 2026</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: right; white-space: nowrap;">October 31, 2025</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; background-color: #e6efff; padding-left: 5.4pt;">Furniture and fixtures</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;">661</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; text-align: right; background-color: #e6efff;">400</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Lab equipment</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right;">30,085</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right;">-</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; background-color: #e6efff; padding-left: 5.4pt;">Computer equipment</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right; background-color: #e6efff;">18,366</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right; background-color: #e6efff;">18,268</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;"> </td> <td colspan="1" style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; text-align: right;">49,112</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; text-align: right;">18,668</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 0.75pt solid #000000; background-color: #e6efff; padding-left: 5.4pt;">Less: accumulated depreciation</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right; background-color: #e6efff;">10,712</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; text-align: right; background-color: #e6efff;">7,431</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 2.25pt double #000000; padding-left: 5.4pt;">Fixed Assets, net</td> <td style="width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right;">38,400</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right;">11,237</td> </tr> </table> </div>

661

400

30085

18366

18268

49112

18668

10712

7431

38400

11237

4925

2831

<div> 5. Taxes Receivable The Company has filed with the Canada Revenue Agency ("CRA") a Goods and Services Tax ("GST") return to claim the GST paid on Canadian expenses paid between September 21, 2024 (date of registration) and up to April 10, 2025, when the Company continued from the jurisdiction of British Columbia, Canada to a newly incorporated Nevada corporation and no longer qualified for claiming any GST paid. The outstanding amount due at April 30, 2026, and October 31, 2025, was $0 and $3,037, respectively. </div>

3037

87500

0.08

3.6905

71326

71328 19327 3.69

40060

50000

98117

136539

163949

176884

12935

1133

22754

9819

136539

0.15

98117

136539

148037

213795

27256

50000

1383

4993

5016 769 4246

18475

6158

12317

3722 3722 7500 10000

82500

82500 66000

0.8

26686

92686

25000

113500

10000 1000000

0.001

250000

99778

250000

99782

250000 80000000

99783

250000

99782

11362

23107

50000

7500 10000 9900

19800

27500

19800

50000

45000

15000

45000

60000

0 72390 1000000

0.001

250000

99778

250000

99782

250000 80000000

99783

250000

99782

11362

23107

12500

37500

75000

100000 0 0 2000000

0.001

500000

199555

500000

199563

500000 80000000

199566

500000

199563

22724

46213

15000

30000

0 0 500000

500

10000

100000

0.4

57527

9116

240000 20000 35000 3000 0.005

87861

2 175723

45000

15000

30000

15000

9900

0.025

5000000

29700

59400

29700

19434

2.3

44700 300000 25000 2000 0.025

439306

878612 0.005

87861

0.005

87861

105289

197547

505347

15000

1500 4000

11200

17500

400 0

10875

13594

640

10235 216000 18000 0.0025

43931

87861

6000

10000 4676

50000

0.4

18553

4524

9200

2033 240000 20000 0.005

87861

175723

10000

15000

869566

2.3

2000001

15000

30000

15000 100000 25000 6818 25000 41667

17424

352174

2.3

810000

262500

1050000

15000

30000

10869

2.3

24999

15000

<div> 11. Share capital Private Placements - Non-brokered The Company closed several non-brokered private placements in December 2024 and January 2025. The private placements consisted of units which were comprised of 1 share of common stock and 1 warrant. The warrants vested immediately, have a two-year life, and an exercise price equal to the price of the unit in the private placement. The price of the units of the private placements was $0.80. The Company issued a total of 687,500 shares for total proceeds of $550,000. The Company closed a non-brokered private placement in May 2025. The private placement consisted of units which were comprised of 1 share of common stock and 1 warrant. The warrants vested immediately, have a two-year life, and an exercise price equal to the price of the unit in the private placement. The price of the units of the private placements was $0.40. The Company issued a total of 3,750,000 shares for total proceeds of $1,500,000. During the year ended October 31, 2025, in connection with the private placements the Company incurred costs of $31,587. On October 23, 2025, the Company received board approval, to open a non-brokered private placement of up to $10,000,000, offering shares at a price of $2.30 per share. On October 28, 2025, the Company closed the first tranche and issued 891,306 shares for total proceeds of $2,050,004. During this private placement, the Company issued 869,566 shares for total proceeds of $2,000,002, to a company to which a member of the board of directors is related. On November 12, 2025, the Company closed the second tranche of the non-brokered private placement and issued 87,956 shares for total proceeds of $202,299. The Company incurred $7,000 of offering costs in connection with this non-brokered private placement. During this private placement, the Company issued 10,869 common shares of the Company at $4.00 per share for a total investment of $24,999 to a company to which a member of the board of directors is related On January 26, 2026, the Company closed the third and final tranche of the non-brokered private placement and issued 352,174 shares for total proceeds of $810,000 to a company to which a member of the board of directors is related On January 20, 2026, the Company received board approval, to open a non-brokered private placement of up to $5,000,000, offering shares at a price of $4.00 per share. On March 23, 2026, the Company closed the non-brokered private placement and issued 486,970 shares at a price of $4.00 per share for total proceeds of $1,947,880. The Company incurred $9,828 of offering costs in connection with this non-brokered private placement. <div> </div> Private Placements - Brokered On July 31, 2025, the Company filed with the Securities and Exchange Commission ("SEC") a Regulation Crowdfunding ("Reg CF") to raise up to $5,000,000 at a price of $2.00 per common share of the Company. On September 2, 2025, the first tranche of the raise was closed with total gross proceeds of $2,726,303, representing a commitment of the Company to issue 1,363,151 common shares. After associated fees and costs of $278,364, the net amount of $2,447,938 was advanced to the Company. On September 18, 2025, a second tranche of the raise was closed with total gross proceeds of $1,969,970, representing a commitment of the Company to issue 984,985 common shares. After associated fees and costs of $200,100, the net amount of $1,769,860 was advanced to the Company. On October 7, 2025, the third and final tranche of the raise was closed with total gross proceeds of $303,652, representing a commitment of the Company to issue 151,826 common shares. After associated fees and costs of $31,299, the net amount of $272,353 was advanced to the Company. With the close of this final tranche, the Company issued a total of 2,499,962 common shares with total gross proceeds equaling $4,999,925 less total issuance costs of $509,773 for a net amount received of $4,490,152. In connection with these raises the Company also issued 49,999 shares of common stock to the broker with a fair value of $99,998. The fair value of the warrants issued in the private placements during the six months ended April 30, 2026, and the year ended October 31, 2025, was determined using the following Black-Scholes Pricing model assumptions: <div> <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2026 </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> October 31, 2025 </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> Share price </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> $0.80 </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> Exercise price </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> $0.40 - $0.80 </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> Expected life </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> 2.00 - 3.00 years </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> Volatility </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> 102.64% to 122.96% </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> Risk-free interest Rate </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> 3.69% - 4.31% </td> </tr> </table> </div> Shares Issued for Services On May 8, 2025, the Company entered into a service agreement in which it was agreed that the consultant would provide advisory and consultancy services related to the Company's Form C disclosure documents required for a planned Regulation Crowdfunding ("Reg CF") offering, advising the Company on marketing, organizational and financial issues and business development. The agreement was for a twelve (12) month period from its effective date of May 8, 2025, and includes a one-time cash payment of $75,000 as a retainer to be expensed monthly over the term of the agreement and is included in the consulting expense on the unaudited condensed interim statements of operations. As of October 31, 2025, a balance of $37,500 remained outstanding and was included in the prepaid expenses on the condensed balance sheets. In addition to performing the defined services, the vendor was to make a one-time purchase of 1,200,000 shares of the Company's common stock at a price of $0.001 per share for gross proceeds of $1,200 which is accounted for as a reduction of the fair value of the shares issued. The fair value of the shares was determined to be $480,000, which, net of the $1,200, is to be expensed over the term of the agreement. As of October 31, 2025, $247,927 was included in prepaid expenses on the condensed balance sheet. During the three and six months ended April, 2026, a total of $117,041 and $238,721, respectively, was expensed as consulting fees on the unaudited condensed interim statements of operations and a balance of $9,206 remained in prepaid expense as at April 30, 2026. <div> </div> On June 27, 2025, the Company granted 150,000 Restricted Share Units ("RSUs") to an advisor, having a fair value of $121,091. The RSUs vested immediately and were expensed as consulting expense. The RSUs may not be sold, transferred, pledged, assigned or otherwise alienated or hypothecated, other than under specific circumstances as defined in the Restricted Share Unit Awards Agreement. During the six months ended April 30, 2025, Director 1 received 82,500 shares of common stock for a fair value of $66,000 as disclosed in Note 10 - Related Party Transactions. The stock vested immediately and $66,000 was expensed and is included within management and directors' salaries and fees on the unaudited condensed interim statements of operations. In May 2025, the Company also issued 416,667 shares of common stock to a consultant for a fair value of $166,667, which was expensed over the 24-month term of the agreement. As of October 31, 2025, $126,484 is included in prepaid expenses in the condensed balance sheets. During the three and six months ended April 30, 2026, a total of $20,320 and $41,553 was expensed as consulting fees on the unaudited condensed interim statements of operations and a balance of $84,931 remained in prepaid expense as at April 30, 2026. In May 2025, the Company also issued 442,514 shares of common stock to employees and a Director of the Company as part of their employment and board of director's agreements with a fair value of $885,028. The terms of these agreements were indefinite and the shares vested immediately. On March 17, 2026, the Company issued 19,434 shares at a price of $2.30 per share to a director in settlement of fees owed related to their consulting and director's agreements. The Company recorded a settlement value of $44,698 for the shares issued. Shares Issued for Conversion of Payables During the six months ended April 30, 2025, the Company issued 207,594 shares of common stock with a fair value of $122,898 to settle outstanding payables. These transactions resulted in a gain on conversion of payables of $43,176. Warrants Warrants Issued for Services On January 21, 2025, the Company issued 82,500 warrants to Director 1 for a fair value of $26,686. The warrants vested immediately. During the three and six months ended April 30, 2025, an expense of $26,686 was incurred and was included within management and directors' salaries and fee on the unaudited condensed interim statements of operations. On June 5, 2025, the Company granted milestone warrants to three Directors. The milestones were defined as follows: 1. Milestone 1 - One quarter of the warrants granted Warrants shall vest upon the Company completing and receiving the results of the three-month Collagen Study in Boston, MA. Milestone achieved July 8, 2025. 2. Milestone 2 - Second quarter of the warrants granted shall vest upon the Company listing its shares of common stock in The Nasdaq Stock Market, LLC, or any such other recognized stock exchange in North America. Milestone achieved May 21, 2026. 3. Milestone 3 - Third quarter of the warrants granted shall vest upon the Company's listed shares of common stock trading for at least 20 consecutive trading days at a market capitalization of $80,000,000 or greater in the currency of the recognized stock exchange in North America on which the shares of common stock are listed. 4. Milestone 4 - Fourth and final quarter if the warrants granted shall vest upon the Company submitting a 510(k) application to the FDA. On July 8, 2025, the first milestone was achieved, and the Company recorded a total expense of $399,111 within management and directors' salaries and fees on the unaudited condensed interim statements of operations during the year ended October 31, 2025. <div> </div> The expense for the second and third milestones will be recognized on the date the milestone is met. On May 21, 2026, the second milestone was achieved, see subsequent event note. For the fourth milestone, the Company assessed a greater than 70% probability that this would occur. As of October 31, 2025, the Company anticipated that this would occur on June 30, 2026. As of April 30, 2026, the Company anticipates that this will now occur on February 28, 2027. The expense for the three and six months ended April 30, 2026, was $45,448 and $92,427, respectively, and is included within management and directors' salaries and fees on the unaudited condensed interim statements of operations. See Note 10 - Related Party Transactions for details. In May 2025, the Company issued 416,667 warrants with a fair value of $102,912 to a consultant for a 24-month consulting agreement. As of October 31, 2025, $78,100 was reported as a prepaid expense on the condensed balance sheet. During the three and six months ended April 30, 2026, a total of $13,337 and $25,655, respectively, was expensed as consulting fees on the unaudited condensed interim statements of operations and a balance of $52,445 remained in prepaid expense as of April 30, 2026. On December 23, 2025, a Director of the Company, exercised 500,000 milestone warrants for a total amount of proceeds of $500. The Company issued 500,000 common shares in connection with the warrant exercise. The fair value of the warrants issued as compensation during the six months ended April 30, 2026, and the year ended October 31, 2025, was determined using the following Black-Scholes Pricing model assumptions: <div> <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 35%; padding-right: 5.4pt; padding-left: 33.75pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;">April 30, 2026</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;">October 31, 2025</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt; background-color: #e6efff;">Share price</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; text-align: center; background-color: #e6efff;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; text-align: center; background-color: #e6efff;">$0.40 - $0.80</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Exercise price</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">$0.001 - $0.80</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt; background-color: #e6efff;">Expected life</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center; background-color: #e6efff;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center; background-color: #e6efff;"> 1.00 - 3.15 years </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Volatility</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">105.57% to 139.13%</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1.5pt solid #000000; padding-left: 5.4pt; background-color: #e6efff;">Risk-free interest Rate</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; text-align: center; background-color: #e6efff;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; text-align: center; background-color: #e6efff;">3.90% - 4.19%</td> </tr> </table> </div> The stock price in the model was based on the methodology disclosed in Note 3, the volatility was based on the historical volatility of comparable public companies, and the expected term is determined using the Simplified Method. Warrants Incentive Program On October 1, 2025, the Board of Directors approved a Warrant Exercise Incentive Program (the "Incentive Program"), inviting current warrant holders to exercise their warrants early at the existing exercise price and if they choose to do so, they are then entitled to subscribe for a new full warrant for each warrant exercised, with a purchase price of $0.001, a 36-month expiry date and an exercise price of $2.30. The initial expiry date of the Incentive Program was December 31, 2025, however, on December 15, 2025, the Board agreed to extend the expiry date of the Incentive Program to April 30, 2026. On February 11, 2026, under the Company Incentive Program, an initial group of warrant holders exercised 563,573 warrants for a total amount of proceeds of $427,928 and purchased 563,573 new warrants at $0.001 for an additional $564 for the new warrants. The fair value of the new warrants was calculated as $692,534. <div> </div> The fair value of the warrants issued under the incentive program during the six months ended April 30, 2026 was determined using the following Black-Scholes Pricing model assumptions: <div> <table cellpadding="0" cellspacing="0" style="width: 60%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 51%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;">April 30, 2026</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt; background-color: #e6efff;">Share price</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; text-align: center; background-color: #e6efff;">$2.30</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Exercise price</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">$2.30</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt; background-color: #e6efff;">Expected life</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center; background-color: #e6efff;"> 3.0 years </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Volatility</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">79.42%</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1.5pt solid #000000; padding-left: 5.4pt; background-color: #e6efff;">Risk-free interest Rate</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; text-align: center; background-color: #e6efff;">3.5%</td> </tr> </table> </div> The stock price in the model was based on the methodology disclosed in Note 3, the volatility was based on the historical volatility of comparable public companies, and the expected term is determined using the Simplified Method. A summary of common stock warrant activity during the six months ended April 30, 2026, and the year ended October 31, 2025, is as follows: <div> <div style="margin-left: 18pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: justify;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;">Number of Warrants</td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;">Weighted Average exercise price</td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;">Weighted Average remaining contractual life</td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;">Aggregate intrinsic value</td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;">Outstanding at November 1, 2024</td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">796,559</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">0.75</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;">Granted</td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">8,936,667</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">0.26</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;">Exercised</td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify;">Cancelled/Forfeited</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: justify; background-color: #e6efff;">Outstanding at October 31, 2025</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;">9,733,226</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;">0.30</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"> 3.12 </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;">19,505,021</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;">Granted</td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">563,573</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">2.30</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;">Exercised</td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">1,063,573</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">0.40</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify;">Cancelled/Forfeited</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: justify; background-color: #e6efff;">Outstanding at April 30, 2026</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;">9,233,226</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;">0.41</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"> 2.71 </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;">33,183,795</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: justify;">Exercisable at April 30, 2026</td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%;">6,233,226</td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%;">0.60</td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%;"> 2.04 </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%;">21,186,795</td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div> As at April 30, 2026, there remained an unrecognized stock-based compensation expense for the unvested warrants of $155,236 excluding milestones 2 and 3. Options On June 7, 2025, the Company approved a Stock Incentive Plan (the "Plan") and Stock-Based Compensation Agreement. The Plan allows for a maximum of 3,000,000 common shares to be granted under the Plan. Options Issued for Services On November 1, 2025, a total of 10,000 stock options were granted to an employee with a total fair value of $17,087, the options will vest 12 months from the grant date, the exercise price is $2.30 per share and will expire on November 1, 2030. For the three and six months ended April 30, 2026, the Company recognized under Management and directors' salaries and fees - related parties on the unaudited condensed interim statements of operations related to the value of the options granted and now vested, $4,273 and $8,545, respectively. <div> </div> On February 9, 2026, a total of 200,000 stock options were granted, in allotments of 50,000 each, to a consultant and three advisors with a total fair value of $302,000. Twenty-five percent of the options will vest every three months, the exercise price is $2.30 per share, and the expiration date is February 9, 2031. For the three and six months ended April 30, 2026, the Company recognized under management and directors' salaries and fees on the unaudited condensed interim statements of operations related to the value of the options granted and now vested, $0 and $66,192, respectively. The fair value of the stock options during the six months ended April 30, 2026, and the year ended October 31, 2025, was determined using the following weighted average Black-Scholes Option Pricing model assumptions: <div> <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2026 </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> October 31, 2025 </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> Share price </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> $2.30 </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> $0.40 - $1.01 </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> Exercise price </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> $2.30 </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> $0.40 - $0.80 </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> Expected life </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> 5.00 years </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> 0.50 - 3.00 years </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> Volatility </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> 79.40% - 129.44% </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> 124.45% - 170.85% </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> Risk-free interest Rate </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> 3.50% - 3.56% </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> 3.72% - 4.23% </td> </tr> </table> </div> The stock price in the model was based on the methodology disclosed in Note 3, the volatility was based on the historical volatility of comparable public companies, and the expected term is determined using the Simplified Method. A summary of common stock options activity during the six months ended April 30, 2026, and the year ended October 31, 2025, is as follows. <div> <div style="margin-left: 18pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt;"> <tr> <td style="width: 29%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 1.5pt solid #000000;"> </td> <td style="width: 15%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 1.5pt solid #000000; white-space: nowrap;"> Number of options </td> <td style="width: 15%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 1.5pt solid #000000; white-space: nowrap;"> Weighted Average exercise price </td> <td style="width: 13%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 1.5pt solid #000000; white-space: nowrap;"> Weighted Average remaining contractual life </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> Aggregate intrinsic value </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> Outstanding, November 1, 2024 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> Granted </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> 675,000 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> $0.61 </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> 3.22 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> Exercised </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> Cancelled or forfeited </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> - </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> - </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff; border-top: 0.75pt solid #000000;"> Outstanding, October 31, 2025 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff; border-top: 0.75pt solid #000000;"> 675,000 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff; border-top: 0.75pt solid #000000;"> $0.61 </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff; border-top: 0.75pt solid #000000;"> 3.22 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> Granted </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> 210,000 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> $2.30 </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> 4.77 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> Exercised </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> Cancelled or forfeited </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> 150,000 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> $0.80 </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;"> - </td> </tr> <tr> <td style="background-color: #e6efff; width: 29%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> Outstanding, April 30, 2026 </td> <td style="background-color: #e6efff; width: 15%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> 735,000 </td> <td style="background-color: #e6efff; width: 15%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> $1.05 </td> <td style="background-color: #e6efff; width: 13%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> 3.88 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> 2,167,000 </td> </tr> <tr> <td style="width: 29%; vertical-align: middle; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> Exercisable, April 30, 2026 </td> <td style="width: 15%; vertical-align: middle; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> 425,000 </td> <td style="width: 15%; vertical-align: middle; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> $0.54 </td> <td style="width: 13%; vertical-align: middle; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> 3.38 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> 1,470,000 </td> </tr> </table> </div> </div> As of April 30, 2026, there remained an unrecognized stock-based compensation expense for the unvested options of $270,760. </div>

0.8

687500

550000

0.4

3750000

1500000

31587

10000000

2.3

891306

2050004

869566

2000002

87956

202299

7000

10869

24999

352174

810000

5000000

486970

1947880

9828

5000000

2726303

1363151

278364

2447938

1969970

984985

200100

1769860

303652

151826

31299

272353

2499962

4999925

509773

4490152

49999

99998 <div> <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2026 </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> October 31, 2025 </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> Share price </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> $0.80 </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> Exercise price </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> $0.40 - $0.80 </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> Expected life </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> 2.00 - 3.00 years </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> Volatility </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> 102.64% to 122.96% </td> </tr> <tr> <td style="width: 50%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> Risk-free interest Rate </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> - </td> <td style="width: 25%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> 3.69% - 4.31% </td> </tr> </table> </div>

0.8

0.4

0.8

P2Y

P3Y

1.0264

1.2296

0.0369

0.0431

75000 37500

1200000

0.001

1200

480000

1200

247927

117041 238721

9206

150000

121091

82500

66000 66000

416667

166667

126484

20320 41553

84931

442514

885028

19434

2.3

207594

122898

43176 82500

26686

80000000

399111

45448

92427

416667

102912

78100

13337 25655

52445

500000

500

500000 <div> <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 35%; padding-right: 5.4pt; padding-left: 33.75pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;">April 30, 2026</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;">October 31, 2025</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt; background-color: #e6efff;">Share price</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; text-align: center; background-color: #e6efff;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; text-align: center; background-color: #e6efff;">$0.40 - $0.80</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Exercise price</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">$0.001 - $0.80</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt; background-color: #e6efff;">Expected life</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center; background-color: #e6efff;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center; background-color: #e6efff;"> 1.00 - 3.15 years </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Volatility</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">105.57% to 139.13%</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1.5pt solid #000000; padding-left: 5.4pt; background-color: #e6efff;">Risk-free interest Rate</td> <td style="width: 20%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; text-align: center; background-color: #e6efff;">-</td> <td style="width: 18%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; text-align: center; background-color: #e6efff;">3.90% - 4.19%</td> </tr> </table> </div>

0.4

0.8

0.001

0.8

P1Y

P3Y1M24D

1.0557

1.3913

0.039

0.0419

0.001

2.3

563573

427928

563573 0.001 564

692534

<div> <table cellpadding="0" cellspacing="0" style="width: 60%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 51%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: center; white-space: nowrap;">April 30, 2026</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt; background-color: #e6efff;">Share price</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; text-align: center; background-color: #e6efff;">$2.30</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Exercise price</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">$2.30</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt; background-color: #e6efff;">Expected life</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center; background-color: #e6efff;"> 3.0 years </td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; padding-left: 5.4pt;">Volatility</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; text-align: center;">79.42%</td> </tr> <tr> <td style="margin-top: 0pt; margin-bottom: 0pt; border-bottom: 1.5pt solid #000000; padding-left: 5.4pt; background-color: #e6efff;">Risk-free interest Rate</td> <td style="width: 30%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; text-align: center; background-color: #e6efff;">3.5%</td> </tr> </table> </div>

2.3

P3Y

0.7942

0.035

<div> <div style="margin-left: 18pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt; border-color: #000000;"> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; text-align: justify;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;">Number of Warrants</td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;">Weighted Average exercise price</td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;">Weighted Average remaining contractual life</td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;">Aggregate intrinsic value</td> <td style="vertical-align: bottom; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap; text-align: center;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;">Outstanding at November 1, 2024</td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">796,559</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">0.75</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;">Granted</td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">8,936,667</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">0.26</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;">Exercised</td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify;">Cancelled/Forfeited</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: justify; background-color: #e6efff;">Outstanding at October 31, 2025</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;">9,733,226</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;">0.30</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;"> 3.12 </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: right; width: 10%; background-color: #e6efff;">19,505,021</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify;">Granted</td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">563,573</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">2.30</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; text-align: justify; background-color: #e6efff;">Exercised</td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">1,063,573</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">0.40</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; text-align: right; width: 10%; background-color: #e6efff;">-</td> <td style="vertical-align: bottom; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: justify;">Cancelled/Forfeited</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: right; width: 10%;">-</td> <td style="vertical-align: bottom; border-bottom: 0.75pt solid #000000; text-align: left; width: 2%;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: justify; background-color: #e6efff;">Outstanding at April 30, 2026</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;">9,233,226</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;">0.41</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;"> 2.71 </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%; background-color: #e6efff;"> </td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%; background-color: #e6efff;">33,183,795</td> <td style="vertical-align: bottom; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%; background-color: #e6efff;"> </td> </tr> <tr> <td style="padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: justify;">Exercisable at April 30, 2026</td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%;">6,233,226</td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%;">0.60</td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%;"> 2.04 </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 1%;"> </td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: right; width: 10%;">21,186,795</td> <td style="vertical-align: bottom; border-top: 2.25pt double #000000; border-bottom: 2.25pt double #000000; text-align: left; width: 2%;"> </td> </tr> </table> </div> </div>

796559

0.75

8936667

0.26

9733226

0.3

P3Y1M13D

19505021

563573

2.3

1063573

0.4

9233226

0.41

P2Y8M15D

33183795 6233226

0.6

P2Y14D 21186795 155236

3000000

10000

17087

2.3

4273

8545

200000

50000

302000

2.3

66192

<div> <table cellpadding="0" cellspacing="0" style="width: 80%; border-collapse: collapse; font-size: 10pt; margin-left: auto; margin-right: auto;"> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000;"> </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> April 30, 2026 </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> October 31, 2025 </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> Share price </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> $2.30 </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> $0.40 - $1.01 </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> Exercise price </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> $2.30 </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> $0.40 - $0.80 </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> Expected life </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> 5.00 years </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> 0.50 - 3.00 years </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> Volatility </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> 79.40% - 129.44% </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> 124.45% - 170.85% </td> </tr> <tr> <td style="width: 40%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> Risk-free interest Rate </td> <td style="width: 32%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> 3.50% - 3.56% </td> <td style="width: 26%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 1.5pt solid #000000; background-color: #e6efff;"> 3.72% - 4.23% </td> </tr> </table> </div>

2.3

0.4

1.01

2.3

0.4

0.8

P5Y

P0Y6M

P3Y

0.794

1.2944

1.2445

1.7085

0.035

0.0356

0.0372

0.0423

<div> <div style="margin-left: 18pt;"> <table cellpadding="0" cellspacing="0" style="width: 100%; border-collapse: collapse; font-size: 10pt;"> <tr> <td style="width: 29%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 1.5pt solid #000000;"> </td> <td style="width: 15%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 1.5pt solid #000000; white-space: nowrap;"> Number of options </td> <td style="width: 15%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 1.5pt solid #000000; white-space: nowrap;"> Weighted Average exercise price </td> <td style="width: 13%; vertical-align: top; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 1.5pt solid #000000; white-space: nowrap;"> Weighted Average remaining contractual life </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 1.5pt solid #000000; border-bottom: 0.75pt solid #000000; white-space: nowrap;"> Aggregate intrinsic value </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> Outstanding, November 1, 2024 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> Granted </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> 675,000 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> $0.61 </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> 3.22 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> Exercised </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> Cancelled or forfeited </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> - </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> - </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff; border-top: 0.75pt solid #000000;"> Outstanding, October 31, 2025 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff; border-top: 0.75pt solid #000000;"> 675,000 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff; border-top: 0.75pt solid #000000;"> $0.61 </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff; border-top: 0.75pt solid #000000;"> 3.22 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-top: 0.75pt solid #000000; background-color: #e6efff;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> Granted </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> 210,000 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> $2.30 </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> 4.77 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> Exercised </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; background-color: #e6efff;"> - </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; background-color: #e6efff;"> - </td> </tr> <tr> <td style="width: 29%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> Cancelled or forfeited </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> 150,000 </td> <td style="width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-bottom: 0.75pt solid #000000;"> $0.80 </td> <td style="width: 13%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;"> - </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: top; border-bottom: 0.75pt solid #000000;"> - </td> </tr> <tr> <td style="background-color: #e6efff; width: 29%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> Outstanding, April 30, 2026 </td> <td style="background-color: #e6efff; width: 15%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> 735,000 </td> <td style="background-color: #e6efff; width: 15%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> $1.05 </td> <td style="background-color: #e6efff; width: 13%; vertical-align: middle; border-bottom: 0.75pt solid #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> 3.88 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 0.75pt solid #000000; background-color: #e6efff;"> 2,167,000 </td> </tr> <tr> <td style="width: 29%; vertical-align: middle; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> Exercisable, April 30, 2026 </td> <td style="width: 15%; vertical-align: middle; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> 425,000 </td> <td style="width: 15%; vertical-align: middle; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> $0.54 </td> <td style="width: 13%; vertical-align: middle; border-bottom: 2.25pt double #000000; padding-right: 5.4pt; padding-left: 5.4pt; border-top: 0.75pt solid #000000;"> 3.38 </td> <td style="width: 14%; padding-right: 5.4pt; padding-left: 5.4pt; vertical-align: middle; border-top: 0.75pt solid #000000; border-bottom: 2.25pt double #000000;"> 1,470,000 </td> </tr> </table> </div> </div>

675000

0.61

P3Y2M19D

675000

0.61

P3Y2M19D

210000

2.3

P4Y9M7D

150000

0.8

735000

1.05

P3Y10M17D

2167000

425000

0.54

P3Y4M17D

1470000

270760

4342648

1968360

11175

44700

137377

500000

500

500000

70000

13.5

400000

400

400000

1667

13.74

416667

167083

100000

100

100000

50000

100000

Twenty five percent (25%) of the shares will vest every 3 months for the following twelve months.

150000

5000 7500 6000 12000 7500 15000 270000 incentives include, an annual discretionary bonus, a milestone equity award up to a maximum of 0.75% of the Company’s common shares on an issued and outstanding basis at the time of the equity grant, plus $37,500 upon the date of the completion of a financing of $20 million at a minimum of $150 million pre-money market capitalization. If the financing completed is a minimum of $15 million at a minimum of $150 million pre-money market capitalization, then then two-thirds of the $37,500 or $24,750 will be earned and paid out. During our fiscal quarter ended April 30, 2026, none of our directors or executive officers adopted , modified or terminated any contract, instruction or written plan for the purchase or sale of our securities that was intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) or any "non-Rule 10b5-1 trading arrangement" as defined in Item 408(c) of Regulation S-K. none false false false false